Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: SOLARIS VACCINES, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2024-06-21 to 2025-01-20
Current total value of award: $249723.49
Description: DHA SBIR PHASE I VACCIRAPTOR: HIGH-THROUGHPUT, CONTINUOUS FLOW-THROUGH DEVICE FOR PSORALEN-UVA INACTIVATION OF DENGUE VIRUS